Tuesday 13 October 2026
Export AUTL’s income statement to Excel — free account
Autolus Therapeutics PLC Sponsored ADR
AUTL Healthcare Biotechnology
In the quarter to June 2026, revenue grew 118.4%, EPS grew 16.7% and free cash flow grew 67.6%, each against the same quarter a year earlier.
1.63
0.11
−6.32%
Follow AUTL
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Sep '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — |
Piotroski F-Score |
3 | 5 | 1 | 4 | 5 | — | — | — | — | — |
Altman Z-Score |
(3.17) | (1.04) | (1.57) | (1.37) | 0.24 | 0.27 | 5.22 | — | 32.63 | — |
P/S ratio |
7.03 | 56.97 | 215.42 | 27.16 | 160.56 | 268.76 | 195.49 | — | 0.00 | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — |
Altman Z″-Score (non-manufacturers) |
(6.27) | (0.36) | (6.37) | 0.29 | 1.79 | (1.78) | 4.56 | — | 18.41 | — |
Beneish M-Score |
— | — | — | (1.79) | (2.83) | (2.43) | — | — | — | — |
P/Operating CF |
(7.87) | (15.81) | (47.91) | (12.20) | (40.85) | (16.62) | (17.09) | — | (143.58) | — |
P/B ratio |
2.97 | 1.40 | 10.67 | 0.59 | 1.19 | 2.19 | 2.23 | — | 4.70 | — |
Price to Tangible BV |
3.35 | 1.45 | 10.67 | 0.59 | 1.19 | 2.20 | 2.23 | — | 4.71 | — |
EV/Sales |
3.90 | 5.68 | 180.58 | (28.43) | 34.33 | 208.41 | 130.93 | — | 0.00 | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 1.37 | 0.00 | 0.00 | 0.00 | — | 0.00 | — |
EV/Operating CF |
(1.04) | (0.29) | (6.85) | 1.66 | (0.68) | (3.04) | (3.75) | — | (24.42) | — |
EV/FCF |
(0.91) | (0.25) | (6.34) | 1.50 | (0.63) | (2.68) | (3.16) | — | (18.97) | — |
Quick Ratio |
4.44 | 9.70 | 5.37 | 8.88 | 11.80 | 5.46 | 9.68 | 10.76 | 14.42 | 28.17 |
Current Ratio |
5.94 | 10.88 | 6.15 | 9.18 | 12.15 | 5.86 | 9.98 | 11.05 | 15.13 | 1.07 |
Net Debt/EBITDA |
1.16 | 2.31 | 1.11 | 2.67 | 1.88 | 0.64 | 1.33 | 3.80 | 4.42 | 6.29 |
Debt/Assets |
0.00% | 6.34% | 12.76% | 3.92% | 4.08% | 17.19% | 7.81% | 0.08% | 0.08% | 0.00% |
Debt/Equity |
0.00 | 0.12 | 0.43 | 0.06 | 0.05 | 0.24 | 0.09 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.11 | 0.02 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 |
Operating CF/Net income |
0.99 | 0.93 | 0.70 | 0.75 | 0.83 | 0.83 | 0.82 | 0.70 | 0.70 | (0.08) |
Capex/Depreciation |
(2.76) | (4.51) | (1.67) | (1.46) | (1.05) | (2.59) | (4.05) | 0.00 | (5.58) | (2.87) |
Interest Coverage |
(7.38) | (25.98) | (3.99) | (16.10) | (149.32) | (313.70) | (57.46) | (76.95) | — | — |
| (94.98%) | (81.91%) | (101.61%) | (48.64%) | (54.30%) | (61.13%) | (50.81%) | (18.34%) | (35.57%) | (64.50%) | |
| (41.92%) | (38.11%) | (48.14%) | (33.23%) | (40.61%) | (47.54%) | (44.41%) | (16.97%) | (32.12%) | (58.09%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | (537.42%) | (98.66%) | (136.01%) | 0.00% | (418.26%) | 0.00% |
Return on Tangible Assets |
(67.49%) | (33.96%) | (78.51%) | (35.90%) | (40.37%) | (70.55%) | (49.06%) | (19.30%) | (17.50%) | (682.49%) |
Average Days of Receivables |
116.32 | 0.54 | 0.00 | 1,661.09 | 4,101.47 | 6,317.80 | 3,831.24 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
156.11% | 1,367.94% | 7,684.39% | 1,845.19% | 5,784.94% | 7,865.19% | 3,625.10% | 0.00% | 2,569.30% | 0.00% |
Selling, General and Administrative Expense of Revenue |
174.93% | 1,005.17% | 2,752.94% | 501.56% | 1,367.60% | 2,039.18% | 1,356.67% | 0.00% | 1,619.76% | 0.00% |
Intangible Assets out of Total Assets |
0.03 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
19.15% | 152.89% | 659.84% | 188.90% | 426.48% | 1,172.42% | 1,038.93% | — | 480.81% | — |
Graham Net Nets |
0.05 | 0.51 | 0.01 | 1.32 | 0.68 | 0.24 | 0.35 | — | 0.20 | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — |
Earnings Yield |
(54.27%) | (36.60%) | (17.40%) | (83.96%) | (38.15%) | (30.87%) | (21.82%) | — | (2.61%) | — |
Free Cash Flow Yield |
(61.13%) | (40.33%) | (13.22%) | (69.74%) | (34.07%) | (28.89%) | (21.21%) | — | (4.19%) | — |
Revenue per Share |
0.28 | 0.04 | 0.01 | 0.07 | 0.03 | 0.03 | 0.07 | 0.00 | 0.04 | 0.00 |
Operating CF per Share |
(1.07) | (0.81) | (0.84) | (1.18) | (1.64) | (2.28) | (2.36) | (1.00) | (1.00) | 0.07 |
Capex per Share |
(0.10) | (0.14) | (0.06) | (0.11) | (0.12) | (0.28) | (0.43) | 0.00 | (0.30) | (0.06) |
Free Cash Flow per Share |
(1.17) | (0.94) | (0.90) | (1.30) | (1.76) | (2.57) | (2.79) | (1.00) | (1.30) | 0.01 |
Cash per Share |
1.14 | 2.31 | 1.38 | 4.03 | 4.31 | 2.99 | 4.91 | 6.89 | 7.83 | 2.70 |
Shareholders Equity per Share |
0.67 | 1.67 | 0.64 | 3.14 | 4.35 | 4.07 | 5.92 | 7.37 | 8.10 | (0.08) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.67 | 1.67 | 0.64 | 3.14 | 4.35 | 4.07 | 5.92 | 7.37 | 8.10 | (0.08) |
Free Cash Flow |
(310.70) | (241.09) | (156.57) | (123.15) | (126.72) | (132.44) | (120.15) | (31.54) | (41.07) | 0.49 |
Working Capital |
362.48 | 600.19 | 230.57 | 379.41 | 318.40 | 163.35 | 224.27 | 211.89 | 242.14 | 0.38 |
Capital Expenditures |
(27.13) | (34.82) | (10.99) | (10.84) | (8.86) | (14.68) | (18.67) | (9.53) | (9.53) | (2.87) |
Net Current Asset Value |
24.98 | 305.53 | 11.40 | 234.17 | 254.71 | 112.78 | 200.56 | 211.40 | 241.54 | (0.65) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 1.30 | 0.00 | 0.00 | 0.00 | — | 0.00 | — |
Capex to Sales |
0.36 | 3.44 | 6.47 | 1.70 | 3.80 | 8.56 | 6.42 | — | 6.77 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.15 | 0.16 | 0.19 | 0.21 | 0.25 | 0.15 | 0.16 | 0.09 | 0.13 | 0.16 |
Cash ROIC |
(64.68%) | (22.61%) | (39.17%) | (17.58%) | (19.78%) | (31.94%) | (24.52%) | (7.00%) | (8.17%) | 0.37% |
Accounts Receivable Turnover |
6.27 | 0.70 | 0.00 | 0.23 | 0.08 | 0.06 | 0.15 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
38.15 | 10.99 | 0.00 | 0.00 | 0.00 | 0.00 | 2.98 | 0.68 | 0.00 | 0.00 |
Inventory Turnover |
5.16 | 0.00 | — | — | — | — | 0.00 | 0.00 | — | 0.00 |
Average Days of Payables |
11.68 | 63.11 | 0.00 | 0.00 | 0.00 | 0.00 | 85.10 | 431.85 | 0.00 | 0.00 |
Days of Inventory on Hand |
125.78 | 132.64 | — | — | — | — | 0.00 | 0.00 | — | 0.00 |
Average Receivables |
12.02 | 14.48 | — | 27.56 | 27.93 | 30.10 | 19.89 | 7.00 | — | 3.46 |
Average Payables |
2.53 | 1.04 | 0.32 | 0.48 | 1.35 | 1.67 | 1.55 | 2.53 | 2.49 | — |
Average Inventory |
18.67 | — | — | — | — | — | — | — | — | — |
Average Assets |
685.90 | 579.05 | 432.83 | 447.92 | 349.90 | 298.89 | 278.87 | 263.71 | 139.31 | 77.04 |
Average Common Equity |
302.73 | 269.40 | 205.07 | 306.00 | 261.68 | 232.44 | 243.74 | 244.05 | 125.81 | 69.38 |
Columns are period end dates · fundamentals updated 28 Sep 2026